NCT06011681

The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over

The Proactive Screening and Diagnosis of Mild Cognitive Impairment and Depression in Patients Ages 60 and Over: An Implementation Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 960 (estimated)
• Sponsor: Miro Health · Academic / Other
• Sex: All
• Age: 60 Years
• Healthy volunteers: Accepted

Summary

Mild cognitive impairment (MCI) leading to Alzheimer's disease and related disorders (ADRD) represents a significant health and economic burden of the rapidly expanding senior population. The accurate detection and diagnosis of MCI and its common comorbidity, late-life depression (LLD), is essential for prolonging patient quality of life and developing advancements in research and treatment options. The purpose of the proposed program is to refine Miro Health's A.I. to accurately detect, differentiate and diagnose MCI and LLD.

Conditions

• Depression
• Mild Cognitive Impairment

Timeline

• Start date: 2023-09-08
• Primary completion: 2024-11-30
• Completion: 2024-12-31
• First posted: 2023-08-25
• Last updated: 2024-01-22

Locations

2 sites across 1 country: United States